三期研究成功,再鼎找到胃癌治疗的那片关键“拼图”

医曜
Jul 01, 2025

本文系基于公开资料撰写,仅作为信息交流之用,不构成任何投资建议。尽管近年来,晚期胃癌的治疗手段不断丰富,但仍存在极为明显的治疗缺口。对于攻克“胃癌”这道人类考题,现有的答案远远达不到优秀的程度。6月30日,再鼎医药公布其贝玛妥珠单抗首个3期临床研究取得阳性结果,我们距离优秀的答案又进了一步。再鼎医药宣布,贝玛妥珠单抗的III期FORTITUDE-101临床研究在预设的中期分析中达到了其主要终点总...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10